Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5196582
Max Phase: Preclinical
Molecular Formula: C31H42N4O3
Molecular Weight: 518.70
Associated Items:
ID: ALA5196582
Max Phase: Preclinical
Molecular Formula: C31H42N4O3
Molecular Weight: 518.70
Associated Items:
Canonical SMILES: CN1C=C2C[C@@H]3[C@H](C[C@@H](CNC(=O)[C@H](Cc4ccccc4)NC(=O)OC(C)(C)C)CN3C)C3C=CC=C1C23
Standard InChI: InChI=1S/C31H42N4O3/c1-31(2,3)38-30(37)33-25(15-20-10-7-6-8-11-20)29(36)32-17-21-14-24-23-12-9-13-26-28(23)22(19-35(26)5)16-27(24)34(4)18-21/h6-13,19,21,23-25,27-28H,14-18H2,1-5H3,(H,32,36)(H,33,37)/t21-,23?,24+,25-,27+,28?/m0/s1
Standard InChI Key: NARMXQGQEAHIKC-TXEQHIETSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 518.70 | Molecular Weight (Monoisotopic): 518.3257 | AlogP: 4.09 | #Rotatable Bonds: 6 |
Polar Surface Area: 73.91 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.72 | CX Basic pKa: 10.09 | CX LogP: 2.84 | CX LogD: -0.37 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.59 | Np Likeness Score: 0.40 |
1. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L, Bhando T, Ritchie NE, Saliba P, Brown ED, Magolan J.. (2022) Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery., 13 (2.0): [PMID:35178184] [10.1021/acsmedchemlett.1c00648] |
Source(1):